Organogenesis Holdings (ORGO) Net Income towards Common Stockholders (2017 - 2025)
Historic Net Income towards Common Stockholders for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $14.5 million.
- Organogenesis Holdings' Net Income towards Common Stockholders rose 1779.26% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.4 million, marking a year-over-year decrease of 8147.7%. This contributed to the annual value of -$937000.0 for FY2024, which is 11894.84% down from last year.
- Per Organogenesis Holdings' latest filing, its Net Income towards Common Stockholders stood at $14.5 million for Q3 2025, which was up 1779.26% from -$12.2 million recorded in Q2 2025.
- Organogenesis Holdings' 5-year Net Income towards Common Stockholders high stood at $51.0 million for Q4 2021, and its period low was -$21.6 million during Q1 2025.
- For the 5-year period, Organogenesis Holdings' Net Income towards Common Stockholders averaged around $5.0 million, with its median value being $5.3 million (2023).
- Per our database at Business Quant, Organogenesis Holdings' Net Income towards Common Stockholders skyrocketed by 137302.33% in 2023 and then crashed by 92814.29% in 2025.
- Organogenesis Holdings' Net Income towards Common Stockholders (Quarter) stood at $51.0 million in 2021, then tumbled by 85.32% to $7.5 million in 2022, then tumbled by 107.59% to -$568000.0 in 2023, then skyrocketed by 1134.33% to $5.9 million in 2024, then skyrocketed by 147.23% to $14.5 million in 2025.
- Its last three reported values are $14.5 million in Q3 2025, -$12.2 million for Q2 2025, and -$21.6 million during Q1 2025.